Characterization of clinical risk factors for enhanced molecular residual disease monitoring in resected early-stage non-small cell lung cancer
Yunfei Shi(Kunming Medical University), Jin Duan(Kunming Medical University), Fujun Zhang(Beijing Jiaotong University), Li Bian(Regeneron (United States)), Guoli Lv, Jiani C. Yin(University Health Network), Qingmei Yang(Shanghai Public Health Clinical Center), Yinqiang Liu(Kunming Medical University), Zhao Wei(Kunming Medical University), Xiaoyu Luo(Northwest A&F University), Haoyu Li(Qingdao University), Tiejun Wang(Kunming Medical University), Yong Liu(Army Medical University), Ya Ma(Genesee Community College), Kang Luo(Kunming Medical University), Youming Lei(Kunming Medical University), Fanghao Liu(Kunming Medical University)
Cited by 0
Related Papers
Eicosapentaenoic and docosahexaenoic acids attenuate hyperglycemia through the microbiome-gut-organs axis in db/db mice
|Microbiome|2021|167
Controlling Morphology and Voltage Loss with Ternary Strategy Triggers Efficient All-Small-Molecule Organic Solar Cells
|ACS Energy Letters|2023|120
Intracellular Porphyromonas gingivalis Promotes the Proliferation of Colorectal Cancer Cells via the MAPK/ERK Signaling Pathway
|Frontiers in Cellular and Infection Microbiology|2020|111